Stockreport

Genmab Announces Financial Results for the First Nine Months of 2024 [Yahoo! Finance]

Genmab A/S - American Depositary Shares  (GMAB) 
PDF European Commission (EC) granted conditional marketing authorization for TEPKINLY ® (epcoritamab) as a monotherapy for the treatment of adult patients with relapsed or [Read more]